CRISPR THERAPEUTICS AG's ticker is and the CUSIP is H17182958. A total of 5 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $549 | -99.9% | 13,500 | 0.0% | 0.00% | – |
| Q3 2022 | $882,000 | +7.6% | 13,500 | 0.0% | 0.00% | – |
| Q2 2022 | $820,000 | -3.2% | 13,500 | 0.0% | 0.00% | – |
| Q1 2022 | $847,000 | -0.1% | 13,500 | -34.8% | 0.00% | – |
| Q3 2019 | $848,000 | -41.4% | 20,700 | -35.1% | 0.00% | – |
| Q2 2019 | $1,447,000 | -7.9% | 31,900 | -42.0% | 0.00% | – |
| Q4 2018 | $1,571,000 | -59.3% | 55,000 | -36.8% | 0.00% | -100.0% |
| Q3 2018 | $3,858,000 | +31.3% | 87,000 | +74.0% | 0.00% | 0.0% |
| Q2 2018 | $2,938,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 225 | $3,445,000 | 0.13% |
| GROUP ONE TRADING, L.P. | 355,400 | $54,415,000 | 0.09% |
| Marathon Trading Investment Management LLC | 3,400 | $521,000 | 0.03% |
| SIMPLEX TRADING, LLC | 413 | $6,323,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |